Clinical Trial Update: Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study [Phase 2]

View source ↗

Summary

Phase 2 window-of-opportunity trial evaluating preoperative nivolumab in locally advanced colon cancer (T3/T4) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Colon Cancer Stage II/III | Phase 2 | Status: COMPLETED